Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease-Reference-Cited by-同舟云学术

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

Published:2024-08-09 Issue: Volume: Page:
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J Neural Transm

Author:

Guedi Ali Barreh,Ikram Sghaier,Youssef Abida,Alya Gharbi,Amira Souissi,Saloua Mrabet,Amina Nasri,Mouna Ben Djebara,Imen Kacem,Amina Gargouri-Berrechid,Riadh Gouider

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00702-024-02815-w.pdf

Reference46 articles.

1. Ahmadi A, Fredrikson M, Jerregård H et al (2000) GSTM1 and mEPHX polymorphisms in Parkinson’s Disease and Age of Onset. Biochem Biophys Res Commun 269:676–680. https://doi.org/10.1006/bbrc.2000.2338

2. Bandres-Ciga S, Ahmed S, Sabir MS et al (2019) The Genetic Architecture of Parkinson Disease in Spain: characterizing Population-Specific Risk, Differential Haplotype structures, and providing Etiologic Insight. Mov Disord 34:1851–1863. https://doi.org/10.1002/mds.27864

3. Barreh GA, Sghaier I, Abida Y et al (1713798001) LRRK2 G2019S impact on Parkinson disease; clinical phenotype and treatment in Tunisian patients. JMD. https://doi.org/10.14802/jmd.23276

4. Beal MF, Chiluwal J, Calingasan NY et al (2020) Isotope-reinforced polyunsaturated fatty acids improve Parkinson’s disease-like phenotype in rats overexpressing α-synuclein. Acta Neuropathol Commun 8:220. https://doi.org/10.1186/s40478-020-01090-6

5. Ben Jemaa S, Attia Romdhane N, Bahri-Mrabet A et al (2017) An Arabic Version of the Cognitive Subscale of the Alzheimer’s Disease Assessment Scale (ADAS-Cog): reliability, validity, and normative data. J Alzheimers Dis 60:11–21. https://doi.org/10.3233/JAD-170222